Paul Kenna
Founder at Spark Therapeutics Ireland Ltd.
Profile
Paul Kenna is the founder of Spark Therapeutics Ireland Ltd.
He is currently the Director-Ocular Genetics Unit at Trinity College Dublin since 2011.
Additionally, he holds positions as a Member at The Royal College of Physicians and the Irish College of Ophthalmologists.
Dr. Kenna obtained a doctorate degree from Trinity College Dublin.
Paul Kenna active positions
| Companies | Position | Start |
|---|---|---|
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Founder | - |
| Trinity College Dublin | Corporate Officer/Principal | - |
| The Royal College of Physicians | Corporate Officer/Principal | - |
| Irish College of Ophthalmologists | Corporate Officer/Principal | - |
Training of Paul Kenna
| Trinity College Dublin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Paul Kenna